PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer. Yadav D, Dutruel SP, O'Dwyer E, Ricaurte-Fajardo A, et al. Eur J Radiol 2024;180:111711.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yadav D, Dutruel SP, O'Dwyer E, Ricaurte-Fajardo A, et al. PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer. Eur J Radiol 2024;180:111711.
PMID: 39226675